Diagnostic utility of anti-tissue transglutaminase antibodies in children with chronic digestive symptoms and suspected of celiac disease
Keywords:
signs and symptoms, digestive, chronic disease, antibodies/diagnostic use, celiac disease, childAbstract
Introduction: Celiac disease is the most common chronic enteropathy in the world, but its occurrence in children with chronic gastrointestinal symptoms in our environment is unknown. Objective: To evaluate the diagnostic utility of anti-tissue transglutaminase antibodies in children with chronic digestive symptoms. Methods: A prospective study was carried out from January 2008 to April 2011 at the José Luis Miranda Pediatric University Hospital in Santa Clara. It included 535 infants in which anti-tissue transglutaminase antibodies was screened. Duodenal transendoscopic biopsies were taken, which were interpreted according to the Marsh-Oberhuber classification and were related to the serological test. The diagnostic efficacy of the antibodies was assessed and the frequency of celiac disease was estimated. Results: Only 11 patients were positive for antibody determination (2.1%). The predominant type of anatomo-pathologic lesion in patients who were positive for antibodies was typical of celiac disease (9 boys, 75%). There was an agreement between the serological and histopathological diagnosis of the duodenum (K=0.78, p<0.001). The frequency of celiac disease in the series was 2.2% (12 patients). The sensitivity and specificity of the antibodies was 75% and 99% respectively. Conclusions: There was a low frequency of celiac disease in the series, and a good diagnostic accuracy of the serological tests in children suspected of suffering the disease was achieved.Downloads
Downloads
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).